Daiwa Securities Group
KMTS

Daiwa Securities Group’s Kestra Medical Technologies KMTS Stock Holding History

Daiwa Securities Group’s Portfolio KMTS Stock Details KMTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,732
Closed -$72K – 1485
2025
Q4 		$72K Buy
+2,732
New +$70.4K ﹤0.01% 1069

Other funds holding KMTS

BCI
Bain Capital Investors Boston, Massachusetts $3.27B AUM 3.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AP
Andera Partners Paris $177M AUM
YF
Yu Fan $97M AUM 57.2% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Daiwa Securities Group's KMTS Position: Q1 2026 in Review

Daiwa Securities Group sold out of Kestra Medical Technologies (KMTS) in Q1 2026, closing a stake of 2,732 shares — an estimated $72K sold.

Daiwa Securities Group first reported a position in KMTS in Q4 2025 and held it in 1 quarter. The position peaked at $72K in Q4 2025. 103 funds tracked by Wall St. Rank hold KMTS as of Q1 2026.

  • Daiwa Securities Group reported no remaining Kestra Medical Technologies position as of Q1 2026 after selling out during the quarter.
  • Daiwa Securities Group sold 2,732 Kestra Medical Technologies shares in Q1 2026, an estimated $72K.
  • Daiwa Securities Group first reported a position in Kestra Medical Technologies in Q4 2025 and held it in 1 quarter.
  • Daiwa Securities Group's Kestra Medical Technologies position peaked at $72K in Q4 2025.
  • 103 funds tracked by Wall St. Rank held Kestra Medical Technologies as of Q1 2026.

Based on Daiwa Securities Group's 13F filing for Q1 2026, filed 13 May 2026.